JPH06104121B2 - Oxygenator - Google Patents

Oxygenator

Info

Publication number
JPH06104121B2
JPH06104121B2 JP4164678A JP16467892A JPH06104121B2 JP H06104121 B2 JPH06104121 B2 JP H06104121B2 JP 4164678 A JP4164678 A JP 4164678A JP 16467892 A JP16467892 A JP 16467892A JP H06104121 B2 JPH06104121 B2 JP H06104121B2
Authority
JP
Japan
Prior art keywords
oxygen
blood
liquid
tank
artificial lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4164678A
Other languages
Japanese (ja)
Other versions
JPH06219A (en
Inventor
信太郎 福永
泰二郎 末田
喜晴 濱中
雄一郎 松浦
Original Assignee
広島大学長
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 広島大学長 filed Critical 広島大学長
Priority to JP4164678A priority Critical patent/JPH06104121B2/en
Publication of JPH06219A publication Critical patent/JPH06219A/en
Publication of JPH06104121B2 publication Critical patent/JPH06104121B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は人工心肺に使用する血液
酸素加装置,或いは肺機能不全の際に使用する血液ガス
交換装置等の体外循環装置に適用される人工肺装置に関
する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a blood oxygenator for use in a heart-lung machine, or an artificial lung device applied to an extracorporeal circulator such as a blood gas exchanger used in the case of pulmonary insufficiency.

【0002】[0002]

【従来の技術】開心術の際,人工心肺に使用する血液酸
素加装置、或いは機能不全に陥った肺を補助するために
使用する血液ガス交換装置等における血液体外循環装置
においては血液を酸素加する目的で従来,気泡型人工肺
が使用されている。
2. Description of the Related Art During open heart surgery, oxygen is added to blood in an oxygenator for blood used in a heart-lung machine or an extracorporeal blood circulation device in a blood gas exchanger used for assisting a dysfunctional lung. Conventionally, a bubble type oxygenator has been used for the purpose.

【0003】この装置は純酸素,或いは酸素と空気の混
合気体を微細に気泡化して上記循環血液中を流すことに
より,気泡と血液との接触境界面においてガス交換を行
わせるようにしたものである。これによれば酸素加の効
率は比較的良いとされているがその反面,血液が気泡と
直接接触するために赤血球の破壊,即ち溶血が起こり易
く、そのため使用時間は精々4〜5時間に限定されると
いうのが実状である。
[0003] This device is a device in which pure oxygen or a mixed gas of oxygen and air is made into fine bubbles and flows in the circulating blood so that gas exchange is performed at the contact interface between the bubbles and blood. is there. According to this, the efficiency of oxygen addition is relatively good, but on the other hand, the blood is in direct contact with the air bubbles, so that red blood cells are easily destroyed, that is, hemolysis is likely to occur, so the usage time is limited to 4 to 5 hours at best. The reality is that it will be done.

【0004】又,最近は,上記気泡型人工肺に代わって
膜型人工肺が多用されつつあり、この装置は微細孔を形
成した高分子材料からなる人工膜を、血液と含酸素気体
との間に介在させ、該膜を介してガス交換が行わせるよ
うになっている。このようにすれば上述のごとき溶血は
少ないとされているものの,血液中の蛋白質による上記
膜孔の目詰まりや血漿の漏出が起こり、従ってその使用
時間はやはり7〜8時間が限界とされている。
Recently, a membrane-type artificial lung is being widely used in place of the above-mentioned bubble-type artificial lung, and in this device, an artificial membrane made of a polymer material having fine pores is used for separating blood and oxygen-containing gas. Gas is exchanged through the membrane by interposing it in between. In this way, although hemolysis as described above is said to be small, clogging of the membrane pores and leakage of plasma occur due to proteins in the blood, and therefore the usage time is still limited to 7-8 hours. There is.

【0005】[0005]

【発明が解決しようとする課題】本発明は上述のごとき
事情に着目してなされたもので、その目的とするところ
は,血液と気泡とが直接接触する気泡型人工肺における
溶血や、人工膜の微細孔を介してガス交換を行う膜型人
工肺での血漿流出や目詰まり等,不本意な結果を生じな
いように構成された人工肺装置を提供することにある。
SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and an object thereof is to obtain hemolysis in an artificial lung of a bubble type in which blood and bubbles are in direct contact with each other and an artificial membrane. An object of the present invention is to provide an oxygenator which is configured so as not to cause unintended results such as plasma outflow and clogging in a membrane oxygenator that exchanges gas through the micropores.

【0006】[0006]

【課題を解決するための手段】本発明においては人工肺
装置本体内に酸素搬送液体の循環路を形成し、上記搬送
液体の循環路中に、酸素気泡発生装置を備えた酸素搬送
液体酸素加槽と、血液を液滴状に放出する血液放出装置
を備えた血液酸素加槽とを夫々分離して設け、上記液体
酸素加槽において,放出酸素気泡により上記液体を酸素
加すると共に、上記血液酸素加槽においては,上記搬送
液体中の溶存酸素により上記液滴状血液を酸素加するよ
うにしたことを特徴とする人工肺装置である。
In the present invention, a circulation path for an oxygen carrier liquid is formed in a main body of an oxygenator, and an oxygen carrier liquid oxygenator equipped with an oxygen bubble generator is provided in the carrier liquid circulation path. A tank and a blood oxygenation tank provided with a blood discharge device for discharging blood in the form of droplets are separately provided, and in the liquid oxygen addition tank, the liquid is oxygenated by released oxygen bubbles, and the blood is added. The oxygenator tank is an oxygenator which is characterized in that the blood droplets are oxygenated by dissolved oxygen in the carrier liquid.

【0007】[0007]

【作用】上述のごとく構成した人工肺装置により,酸素
搬送液体は、液体酸素加槽内に放出される酸素気泡群に
よって酸素加されると共に,上記酸素気泡群の浮上力に
より付勢され装置本体内部を循環する流れを形成する。
そして溶存酸素を多量に含んだ状態で血液酸素加槽内に
入り、該槽内に放出される液滴状血液に接触しすること
によって酸素加される。従って血液酸素加槽における液
滴状血液は、酸素気泡に直接触れることなく搬送液体と
液面接触し,該液中に含まれる溶存酸素の移行が行われ
る。
With the artificial lung device constructed as described above, the oxygen carrier liquid is oxygenated by the oxygen bubble group discharged into the liquid oxygen addition tank, and is urged by the levitation force of the oxygen bubble group. Form a flow that circulates inside.
Then, it enters the blood oxygenation tank in a state where a large amount of dissolved oxygen is contained therein, and oxygen is added by coming into contact with the droplet-shaped blood released into the tank. Therefore, the droplet-shaped blood in the blood oxygen addition tank comes into contact with the carrier liquid on the liquid surface without directly contacting the oxygen bubbles, and the dissolved oxygen contained in the liquid is transferred.

【0008】[0008]

【実施例】本発明の一実施例を図面を参照して説明すれ
ば、図1は人工肺装置の構成を概略的に示すもので、1
は人工肺装置本体であり、内部には所要量の酸素搬送液
体イ,即ち血液よりも比重が大で,かつ血液と混合せ
ず、酸素溶存性の高い液体、例えばパーフルオルカーボ
ンのような液体が収容されている。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described with reference to the drawings. FIG.
Is the main body of the oxygenator, which contains a required amount of oxygen-carrying liquid (i), that is, a liquid that has a greater specific gravity than blood and that does not mix with blood and that is highly soluble in oxygen, such as perfluorocarbon. A liquid is contained.

【0009】又,上記装置本体1の内部は隔壁2で仕切
られており、該隔壁2のー側に酸素搬送液体の酸素加槽
3、他側に血液酸素加槽4が夫々設けられていると共
に、両槽は隔壁2の上下端部に形成される連通部を介し
て互いに連通し、後述するA 〜D のごとき酸素搬送液体
イの循環路を構成する。
Further, the inside of the apparatus main body 1 is partitioned by a partition 2, and an oxygen supply tank 3 for oxygen carrier liquid is provided on the negative side of the partition 2, and a blood oxygen addition tank 4 is provided on the other side. At the same time, both tanks communicate with each other through the communication portions formed at the upper and lower ends of the partition wall 2 to form a circulation path for oxygen-carrying liquid a such as A to D described later.

【0010】さらに上記搬送液体酸素加槽3の下部に
は、槽外の酸素発生源に供給管5a を介して接続する酸
素気泡発生装置5が設けられており、上記血液酸素加槽
4には、その下部に血液液滴発生装置6、同じくその上
部に血液回収装置7が夫々設けられている。又,上記血
液液滴発生装置6は流入口6a を介して血液流入源,即
ち静脈に接続され、血液回収装置7は流出口7a を介し
て動脈に夫々接続されている。
Further, an oxygen bubble generator 5 connected to an oxygen source outside the tank via a supply pipe 5a is provided below the carrier liquid oxygen tank 3, and the blood oxygen tank 4 is provided in the blood oxygen tank 4. A blood droplet generator 6 is provided below the blood drop generator 7, and a blood recovery device 7 is provided above the blood drop generator 6. The blood droplet generator 6 is connected to a blood inflow source, that is, a vein via an inflow port 6a, and the blood recovery device 7 is connected to an artery via an outflow port 7a.

【0011】以上のように構成され、酸素発生源より供
給管5a を介して搬送液体酸素加槽3に供給される酸素
は、酸素気泡発生装置5から上記酸素加槽内の搬送液体
中に酸素気泡ロとして放出され、該液体イを酸素加する
と共に,酸素気泡群の上昇力により矢印A 方向に押し上
げる。押し上げられた液体イは、隔壁2の上端部2aに
おいて矢印B 方向にオーバーフローし、血液酸素加槽4
に流入する。このオーバーフロー時,酸素気泡群は液中
から離脱し、矢印E 方向に排出される。血液酸素加槽4
に流入した液体イは槽内を矢印C 方向に流下し、さらに
隔壁2の下端部に形成された連通部2b を矢印D 方向に
流れて,再び液体酸素加槽3内にへと戻る。以下同様の
流を反復し,装置本体内を循環路を形成する。
Oxygen having the above-described structure and supplied from the oxygen generation source to the carrier liquid oxygen addition tank 3 through the supply pipe 5a is oxygen in the carrier liquid in the oxygen addition tank from the oxygen bubble generator 5. It is released as bubbles b and adds oxygen to the liquid a and pushes up in the direction of arrow A by the ascending force of the oxygen bubbles. The liquid a pushed up overflows in the direction of arrow B at the upper end 2a of the partition wall 2 and the blood oxygen tank 4
Flow into. At the time of this overflow, the oxygen bubble group is separated from the liquid and discharged in the direction of arrow E. Blood oxygen tank 4
The liquid a that has flowed into the tank flows down in the direction of arrow C in the tank, further flows in the direction of arrow D through the communicating portion 2b formed at the lower end of the partition wall 2, and returns again into the liquid oxygen addition tank 3. The same flow is repeated thereafter to form a circulation path inside the main body of the device.

【0012】一方,患者の静脈から脱血した血液は、血
液流入口6a を介して矢印 F方向から液滴発生装置6に
供給され、該装置に設けられた多数のノズル孔から放出
される。放出された血液は液中において液滴状をなし、
搬送液体イの流れに抗して G方向へと浮上移動する。こ
の移動中,血液液滴ハは、酸素搬送液体イと液面接触
し,液中溶存酸素と血液中に溶存する二酸化炭素との置
換が行われ、酸素加される。液中に移行した二酸化炭素
は、循環する搬送液体によって液体酸素加槽3に運ば
れ、酸素との分圧の差により液中から離脱し、液面から
槽外,E 方向に排出される。
On the other hand, the blood removed from the vein of the patient is supplied to the droplet generator 6 from the direction of the arrow F through the blood inlet 6a, and is discharged from a large number of nozzle holes provided in the device. The released blood forms droplets in the liquid,
Ascends in the direction G against the flow of the carrier liquid a. During this movement, the blood droplet (c) is brought into contact with the oxygen carrier liquid (i) on the liquid surface, the oxygen dissolved in the liquid is replaced with the carbon dioxide dissolved in the blood, and oxygen is added. The carbon dioxide transferred into the liquid is carried to the liquid oxygen addition tank 3 by the circulating carrier liquid, is separated from the liquid due to the partial pressure difference with oxygen, and is discharged from the liquid surface to the outside of the tank in the E direction.

【0013】酸素加された血液液滴群は血液酸素加槽4
の上方に浮上集積し、血液群ニとなって血液回収装置7
に貯留される。該装置7に貯留する血液ニは、さらに流
出口7a より装置本体外部,矢印 H方向に取り出され、
血液ポンプ(図示せず)を介して患者の動脈に送血され
る。
The oxygenated blood droplet group is a blood oxygenation tank 4
Blood collection device 7
Stored in. The blood D stored in the device 7 is further taken out of the device main body in the direction of arrow H from the outlet 7a,
Blood is delivered to the patient's artery via a blood pump (not shown).

【0014】以上のごとく酸素搬送液体イは、液体酸素
加槽3内に発生する酸素気泡群によって,装置本体内を
循環する流れが付与されると共に,上記気泡群との接触
により所望の酸素加を行うことができる。
As described above, in the oxygen-carrying liquid (i), the flow of oxygen bubbles generated in the liquid oxygen addition tank 3 circulates in the main body of the apparatus, and the desired oxygen is added by the contact with the bubbles. It can be performed.

【0015】又,上記酸素気泡群は、隔壁2上端のオー
バーフロー部において,液中から離脱し槽外に排出され
るため、血液酸素加槽4内には酸素が溶存する状態の搬
送液体のみが流入し、従って酸素気泡との接触に起因す
る溶血現象等の虞れもなく血液を酸素加することができ
る。
Further, since the oxygen bubble group is separated from the liquid and discharged out of the tank in the overflow portion at the upper end of the partition wall 2, only the carrier liquid in a state where oxygen is dissolved is stored in the blood oxygen addition tank 4. It is possible to add oxygen to the blood without any fear of a hemolysis phenomenon or the like caused by the inflow of oxygen bubbles.

【0016】さらに血液より比重が大きく,血液に対し
非溶解性の酸素搬送液体を使用することにより、血液酸
素加槽4内に放出する血液を液滴状に形成することがで
き、又,それによって液体との接触面積が大きく、液中
の溶存酸素と血液中の二酸化炭素との置換を効率良く行
うことができる。従って開心術の際,或いは肺機能不全
の回復措置等,長時間の血液酸素加を要する人工肺装置
として、より安全かつ確実に実施できる体外循環装置を
提供することが可能である。
Further, by using an oxygen carrier liquid which has a specific gravity higher than that of blood and is insoluble in blood, the blood discharged into the blood oxygenation tank 4 can be formed into droplets, and As a result, the contact area with the liquid is large, and the dissolved oxygen in the liquid and the carbon dioxide in the blood can be efficiently replaced. Therefore, it is possible to provide an extracorporeal circulation device that can be more safely and surely implemented as an artificial lung device that requires long-time blood oxygenation, such as during open-heart surgery or recovery measures for lung dysfunction.

【0017】[0017]

【発明の効果】人工肺装置本体内に形成した酸素搬送液
体の循環路に,酸素気泡を発生する液体酸素加槽と血液
を液滴状に放出する血液酸素加槽とを夫々分離して設け
ることにより,上記搬送液体は、酸素気泡によって液体
酸素加槽と血液酸素加槽とを循環する流れを生じると共
に、上記血液酸素加槽において,血液は酸素気泡と接触
することなく搬送液体とのみ液面接触し、液中溶存酸素
を取り入れる。従って溶血等を起こすこともなく酸素加
することができる。
EFFECTS OF THE INVENTION A liquid oxygen tank for generating oxygen bubbles and a blood oxygen tank for discharging blood in the form of droplets are separately provided in a circulation path of an oxygen carrier liquid formed in a main body of an oxygenator. As a result, the carrier liquid causes a flow that circulates between the liquid oxygen tank and the blood oxygen tank due to oxygen bubbles, and in the blood oxygen tank, the blood is liquid only with the carrier liquid without contacting the oxygen bubbles. Face-to-face contact and take in dissolved oxygen in the liquid. Therefore, oxygen can be added without causing hemolysis.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は本発明の一実施例である人工肺装置の構
成を概略的に示す図。
FIG. 1 is a diagram schematically showing the configuration of an artificial lung device which is an embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1…人工肺装置本体、2…隔壁、3…液体酸素加槽、4
…血液酸素加槽、5…酸素気泡発生装置、6…血液液滴
発生装置、7…血液回収装置、イ…酸素搬送液体、ロ…
酸素気泡、ハ…血液液滴、A〜D…液体循環路。
1 ... Oxygenator device main body, 2 ... Partition wall, 3 ... Liquid oxygen tank, 4
... blood oxygen addition tank, 5 ... oxygen bubble generator, 6 ... blood droplet generator, 7 ... blood recovery device, a ... oxygen carrier liquid, b ...
Oxygen bubbles, c ... blood droplets, A to D ... liquid circulation path.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭63−40562(JP,A) 特開 昭57−66760(JP,A) 実公 昭48−31278(JP,Y2) ─────────────────────────────────────────────────── ─── Continuation of the front page (56) References JP-A-63-40562 (JP, A) JP-A-57-66760 (JP, A) Jitsuko Sho-48-31278 (JP, Y2)

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 人工肺装置本体内に酸素搬送液体の循環
路を形成し、上記搬送液体の循環路中に、酸素気泡発生
装置を備えた酸素搬送液体酸素加槽と、血液を液滴状に
放出する血液液滴発生装置を備えた血液酸素加槽とを夫
々分離して設け、上記液体酸素加槽において,放出酸素
気泡により上記液体を酸素加すると共に、上記血液酸素
加槽においては,上記搬送液体中の溶存酸素により上記
液滴状血液を酸素加するようにしたことを特徴とする人
工肺装置。
1. An oxygen carrying liquid oxygen addition tank provided with an oxygen bubble generating device, wherein a circulation path for an oxygen carrier liquid is formed in a main body of an oxygenator, and a blood droplet is formed in the oxygen carrier generating device. And a blood oxygenation tank provided with a blood droplet generating device that discharges the liquid oxygen are separately provided in the liquid oxygenation tank, and the liquid oxygen is oxygenated by the released oxygen bubbles, and in the blood oxygenation tank, An artificial lung device, wherein the droplet-shaped blood is oxygenated by dissolved oxygen in the carrier liquid.
【請求項2】 人工肺装置本体内部を、上下に連通部を
有する隔壁によって仕切り、酸素搬送液体の循環路を形
成することを特徴とする請求項1記載の人工肺装置。
2. The artificial lung device according to claim 1, wherein the inside of the artificial lung device main body is partitioned by a partition having upper and lower communicating portions to form a circulation path for the oxygen carrier liquid.
【請求項3】 前記酸素搬送液体が、パーフルオルカー
ボンのような血液よりも比重が大きく,かつ血液とは混
合せず、酸素溶存性の高い液体であることを特徴とする
請求項1及び2のいずれか1項に記載の人工肺装置。
3. The oxygen-carrying liquid is a liquid such as perfluorocarbon, which has a higher specific gravity than blood and is immiscible with blood and is highly oxygen-dissolved. The artificial lung device according to any one of 2 above.
JP4164678A 1992-06-23 1992-06-23 Oxygenator Expired - Lifetime JPH06104121B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4164678A JPH06104121B2 (en) 1992-06-23 1992-06-23 Oxygenator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4164678A JPH06104121B2 (en) 1992-06-23 1992-06-23 Oxygenator

Publications (2)

Publication Number Publication Date
JPH06219A JPH06219A (en) 1994-01-11
JPH06104121B2 true JPH06104121B2 (en) 1994-12-21

Family

ID=15797769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4164678A Expired - Lifetime JPH06104121B2 (en) 1992-06-23 1992-06-23 Oxygenator

Country Status (1)

Country Link
JP (1) JPH06104121B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4831278U (en) * 1971-07-31 1973-04-16
JPS5766760A (en) * 1980-10-09 1982-04-23 Asahi Medical Co Device for purifying blood
EP0249308A3 (en) * 1986-06-13 1989-02-08 BAXTER INTERNATIONAL INC. (a Delaware corporation) O2/co2 control in blood oxygenators

Also Published As

Publication number Publication date
JPH06219A (en) 1994-01-11

Similar Documents

Publication Publication Date Title
US4876066A (en) Integrated membrane oxygenator, heat exchanger and reservoir
US4698207A (en) Integrated membrane oxygenator, heat exchanger and reservoir
EP0283850B1 (en) Device for the extra-corporeal oxygenation of blood and for cardiovascular assistance
WO1989002282A1 (en) Medical instrument and production thereof
US6723284B1 (en) Membrane apparatus with enhanced mass transfer, heat transfer and pumping capabilities via active mixing
JPH05177117A (en) Substance exchange device
JPS6312632B2 (en)
AU6054999A (en) Membrane apparatus with enhanced mass transfer, heat transfer and pumping capabilities via active mixing
US4058369A (en) Oxygenator
JPH06104121B2 (en) Oxygenator
JPH06237992A (en) Heat and gas exchanger
JPH0260657A (en) Blood storage tank
JP3373252B2 (en) Blood reservoir
JPS6340562A (en) Method and apparatus for adding oxygen to blood
JPH06237993A (en) Fluid supply device
JPS6237992B2 (en)
JP2800123B2 (en) Bypass tube
JP7458605B1 (en) Plasma exchange system and control method for plasma exchange system
JP2762360B2 (en) Blood reservoir with pump
JP3360995B2 (en) Artificial heart lung device and oxygenator with blood reservoir
JPH0622619B2 (en) Extracorporeal blood circulation circuit device
JPS59131357A (en) Blood storage tank
JPH0513456U (en) Artificial lung circuit
JPH0467464B2 (en)
Golding et al. A New Hollow‐Fiber Oxygenator for Clinical Cardiopulmonary Bypass

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term